June 12th- IACH Radio: On Air from EHA 2025- Prof. Mohamad Mohty- Relapse after alloHCT in AML: DLI vs second transplant

CME Congresses .

June 12th- IACH Radio: On Air from EHA 2025- Prof. Mohamad Mohty- Relapse after alloHCT in AML: DLI vs second transplant

June 8th- IACH Radio: On Air from EHA 2025- Prof. Mohamad Mohty

CME Congresses .

June 8th- IACH Radio: On Air from EHA 2025- Prof. Mohamad Mohty

June 4th- Dr. Alejandro Luna- CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

CME Congresses .

June 4th- Dr. Alejandro Luna- CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

May 20th- Dr. Minoo Battiwalla- Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

CME Congresses .

May 20th- Dr. Minoo Battiwalla- Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

May 12th- Prof. Christian Chabannon - Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

CME Congresses .

May 12th- Prof. Christian Chabannon – Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

CME Congresses .

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

CME Congresses .

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

CME Congresses .

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

March 20th - Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

CME Congresses .

March 20th Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

March 4th- Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

CME Congresses .

March 4th – Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy